Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01857752 |
|
Recruitment Status :
Terminated
(accrual)
First Posted : May 20, 2013
Last Update Posted : January 30, 2017
|
Sponsor:
Stanford University
Information provided by (Responsible Party):
Stanford University
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | June 2015 |
| Actual Study Completion Date : | June 2015 |